P. Kent Hawryluk, Director at Gemphire Therapeutics Inc. (GEMP), bought 56,889 shares at $10.00 ($414K) on 2016-08-10, disclosed to the SEC on 2016-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,457 | $0 | 0.0% |
| 2 | $6.71 | 816 | $5K | 1.3% |
| 3 | $6.71 | 23,616 | $158K | 38.3% |
| 4 | $10.00 | 25,000 | $250K | 60.4% |
| Total | $7.28 avg | 56,889 | $414K | 100% |
| Filing → |
| MBX | BUY | 2025-10-21 | $273K | — | Filing → |
| MBX | BUY | 2025-02-05 | $535K | — | Filing → |
| GEMP | BUY | 2017-03-14 | $474K | — | Filing → |